irbesartan and hydrochlorothiazide

Generic: irbesartan and hydrochlorothiazide

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name irbesartan and hydrochlorothiazide
Generic Name irbesartan and hydrochlorothiazide
Labeler teva pharmaceuticals usa, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, irbesartan 150 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-8238
Product ID 0093-8238_af80b0d1-ba9d-4d3c-849c-6c7c1a7cfade
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077369
Listing Expiration 2027-12-31
Marketing Start 2013-01-24

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc] angiotensin 2 receptor blocker [epc]
Mechanism of Action
angiotensin 2 receptor antagonists [moa]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00938238
Hyphenated Format 0093-8238

Supplemental Identifiers

RxCUI
310792 310793
UPC
0300938238569
UNII
0J48LPH2TH J0E2756Z7N
NUI
N0000175359 N0000175419 M0471776 N0000000070 N0000175561

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name irbesartan and hydrochlorothiazide (source: ndc)
Generic Name irbesartan and hydrochlorothiazide (source: ndc)
Application Number ANDA077369 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (0093-8238-56)
  • 90 TABLET, FILM COATED in 1 BOTTLE (0093-8238-98)
source: ndc

Packages (2)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) irbesartan (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "af80b0d1-ba9d-4d3c-849c-6c7c1a7cfade", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0300938238569"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792", "310793"], "spl_set_id": ["83f4acc1-697a-4770-b554-1b9a8fb5de74"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0093-8238-56)", "package_ndc": "0093-8238-56", "marketing_start_date": "20130124"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (0093-8238-98)", "package_ndc": "0093-8238-98", "marketing_start_date": "20130220"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "0093-8238_af80b0d1-ba9d-4d3c-849c-6c7c1a7cfade", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0093-8238", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "150 mg/1"}], "application_number": "ANDA077369", "marketing_category": "ANDA", "marketing_start_date": "20130124", "listing_expiration_date": "20271231"}